These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


622 related items for PubMed ID: 8741837

  • 1. TOR controls translation initiation and early G1 progression in yeast.
    Barbet NC, Schneider U, Helliwell SB, Stansfield I, Tuite MF, Hall MN.
    Mol Biol Cell; 1996 Jan; 7(1):25-42. PubMed ID: 8741837
    [Abstract] [Full Text] [Related]

  • 2. Rapamycin induces the G0 program of transcriptional repression in yeast by interfering with the TOR signaling pathway.
    Zaragoza D, Ghavidel A, Heitman J, Schultz MC.
    Mol Cell Biol; 1998 Aug; 18(8):4463-70. PubMed ID: 9671456
    [Abstract] [Full Text] [Related]

  • 3. TOR kinase domains are required for two distinct functions, only one of which is inhibited by rapamycin.
    Zheng XF, Florentino D, Chen J, Crabtree GR, Schreiber SL.
    Cell; 1995 Jul 14; 82(1):121-30. PubMed ID: 7606777
    [Abstract] [Full Text] [Related]

  • 4. Target of rapamycin in yeast, TOR2, is an essential phosphatidylinositol kinase homolog required for G1 progression.
    Kunz J, Henriquez R, Schneider U, Deuter-Reinhard M, Movva NR, Hall MN.
    Cell; 1993 May 07; 73(3):585-96. PubMed ID: 8387896
    [Abstract] [Full Text] [Related]

  • 5. Protein kinase activity and identification of a toxic effector domain of the target of rapamycin TOR proteins in yeast.
    Alarcon CM, Heitman J, Cardenas ME.
    Mol Biol Cell; 1999 Aug 07; 10(8):2531-46. PubMed ID: 10436010
    [Abstract] [Full Text] [Related]

  • 6. The TOR nutrient signalling pathway phosphorylates NPR1 and inhibits turnover of the tryptophan permease.
    Schmidt A, Beck T, Koller A, Kunz J, Hall MN.
    EMBO J; 1998 Dec 01; 17(23):6924-31. PubMed ID: 9843498
    [Abstract] [Full Text] [Related]

  • 7. TOR mutations confer rapamycin resistance by preventing interaction with FKBP12-rapamycin.
    Lorenz MC, Heitman J.
    J Biol Chem; 1995 Nov 17; 270(46):27531-7. PubMed ID: 7499212
    [Abstract] [Full Text] [Related]

  • 8. TOR1 and TOR2 are structurally and functionally similar but not identical phosphatidylinositol kinase homologues in yeast.
    Helliwell SB, Wagner P, Kunz J, Deuter-Reinhard M, Henriquez R, Hall MN.
    Mol Biol Cell; 1994 Jan 17; 5(1):105-18. PubMed ID: 8186460
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The fission yeast TOR homolog, tor1+, is required for the response to starvation and other stresses via a conserved serine.
    Weisman R, Choder M.
    J Biol Chem; 2001 Mar 09; 276(10):7027-32. PubMed ID: 11096119
    [Abstract] [Full Text] [Related]

  • 12. Elucidating TOR signaling and rapamycin action: lessons from Saccharomyces cerevisiae.
    Crespo JL, Hall MN.
    Microbiol Mol Biol Rev; 2002 Dec 09; 66(4):579-91, table of contents. PubMed ID: 12456783
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Regulation of ribosome biogenesis by the rapamycin-sensitive TOR-signaling pathway in Saccharomyces cerevisiae.
    Powers T, Walter P.
    Mol Biol Cell; 1999 Apr 09; 10(4):987-1000. PubMed ID: 10198052
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Mechanism of action of rapamycin: new insights into the regulation of G1-phase progression in eukaryotic cells.
    Wiederrecht GJ, Sabers CJ, Brunn GJ, Martin MM, Dumont FJ, Abraham RT.
    Prog Cell Cycle Res; 1995 Apr 09; 1():53-71. PubMed ID: 9552353
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 32.